Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Kidney Transplantation | 7 | 2021 | 5397 | 0.78 | Why? |
| Calciphylaxis | 1 | 2018 | 29 | 0.76 | Why? |
| Pneumonia, Pneumococcal | 1 | 2020 | 251 | 0.66 | Why? |
| Hemolysis | 1 | 2018 | 283 | 0.61 | Why? |
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2018 | 198 | 0.59 | Why? |
| Superinfection | 1 | 2020 | 459 | 0.58 | Why? |
| Arterial Pressure | 1 | 2017 | 208 | 0.58 | Why? |
| Transplant Recipients | 4 | 2021 | 4982 | 0.47 | Why? |
| Angiotensin II Type 1 Receptor Blockers | 1 | 2017 | 520 | 0.45 | Why? |
| Kidney Diseases | 1 | 2020 | 1434 | 0.39 | Why? |
| Renal Dialysis | 2 | 2018 | 4358 | 0.28 | Why? |
| Antihypertensive Agents | 1 | 2017 | 1962 | 0.28 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.27 | Why? |
| Immunosuppressive Agents | 2 | 2020 | 6331 | 0.25 | Why? |
| Renin-Angiotensin System | 1 | 2017 | 3661 | 0.22 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.20 | Why? |
| Home Care Services, Hospital-Based | 1 | 2020 | 137 | 0.19 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 5277 | 0.19 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.18 | Why? |
| Graft Rejection | 2 | 2018 | 1766 | 0.17 | Why? |
| Spain | 6 | 2021 | 15545 | 0.17 | Why? |
| Hemofiltration | 1 | 2018 | 155 | 0.16 | Why? |
| Hepatitis A | 1 | 2018 | 140 | 0.16 | Why? |
| Hospitals, Urban | 1 | 2021 | 950 | 0.15 | Why? |
| Pyrroles | 1 | 2018 | 292 | 0.15 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.14 | Why? |
| Hospitals, Public | 1 | 2021 | 774 | 0.14 | Why? |
| Patient Transfer | 1 | 2021 | 898 | 0.13 | Why? |
| Renal Insufficiency | 1 | 2020 | 810 | 0.13 | Why? |
| Hospitals, Teaching | 1 | 2021 | 1609 | 0.12 | Why? |
| Hemoglobins | 1 | 2018 | 958 | 0.12 | Why? |
| Antibodies | 1 | 2018 | 846 | 0.12 | Why? |
| Piperidines | 1 | 2018 | 795 | 0.11 | Why? |
| Plasma Exchange | 1 | 2018 | 763 | 0.11 | Why? |
| Rituximab | 1 | 2018 | 1096 | 0.10 | Why? |
| Pyrimidines | 1 | 2018 | 1557 | 0.10 | Why? |
| Protein Kinase Inhibitors | 1 | 2018 | 1585 | 0.09 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.08 | Why? |
| Immunoglobulins, Intravenous | 1 | 2018 | 2705 | 0.08 | Why? |
| Graft Survival | 2 | 2018 | 587 | 0.07 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2017 | 3755 | 0.06 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| Male | 10 | 2021 | 367725 | 0.06 | Why? |
| Humans | 13 | 2021 | 930598 | 0.05 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.05 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.05 | Why? |
| Rats, Inbred F344 | 1 | 2018 | 33 | 0.05 | Why? |
| Rats, Inbred Lew | 1 | 2018 | 45 | 0.05 | Why? |
| Janus Kinase 3 | 1 | 2018 | 46 | 0.05 | Why? |
| Complement C4b | 1 | 2018 | 57 | 0.05 | Why? |
| Preliminary Data | 1 | 2020 | 457 | 0.05 | Why? |
| Aged | 5 | 2021 | 215776 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.04 | Why? |
| Female | 8 | 2021 | 380317 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.04 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.04 | Why? |
| Adult | 4 | 2020 | 244371 | 0.04 | Why? |
| Proteinuria | 1 | 2018 | 474 | 0.04 | Why? |
| Hospital Bed Capacity | 1 | 2021 | 1300 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.03 | Why? |
| Rats | 1 | 2018 | 2764 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2018 | 3614 | 0.02 | Why? |
| Kidney | 1 | 2018 | 3648 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2018 | 4849 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.00 | Why? |
Cucchiari's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(90)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(102)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_